SEC Company Response from Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) (ERNA) — Jun 7, 2005
Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
Date: June 7, 2005 · CIK: 0000748592 · Accession: 0000748592-05-000014
AI Filing Summary & Sentiment
Referenced dates: May 24, 2005
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
June 7, 2005
Mr. Larry Spirgel
Assistant Director
Mail Stop 0407
U.S. Securities and Exchange Commission 450 Fifth Street, N.W.
Washington, D.C. 20549
Re: NTN Communications, Inc.
Form 10-K for the fiscal year ended December 31, 2004
File No. 1-11460
Dear Mr. Spirgel:
On behalf of NTN Communications, Inc. (the "Company"), this letter is being sent
in response to the Staff's letter of comment dated May 24, 2005, with respect to
the above-referenced Form 10-K.
In order to get the full input of our current auditors as well as our previous
auditors in drafting a response to the letter of comment, some of whom have been
traveling internationally during this period, we hereby request an extension of
the time in which we may file a response to the letter of comment until
Thursday, June 16, 2005.
If you have any questions regarding this request please call me at (760)
437-7400.
Sincerely,
/s/ James B. Frakes
James B. Frakes
Chief Financial Officer
NTN Communications, Inc.
</TEXT>
</DOCUMENT>